Program Schedule

Q&A Moderators: Dr. Sari Kives and Dr. Carmen McCaffrey Note regarding interactivity: Every lecture will be followed by 10 minutes of Q&A.

WHS Course Director

At the conclusion of this session, participants will be able to: • Analyze the latest advancement in menopause treatment options including hormone replacement treatment to evaluate their suitability for different patient needs; • Evaluate the role of androgen replacement in menopause treatment. This session will provide an evidence-based overview of menopause hormone therapy (MHT), helping clinicians identify appropriate candidates, understand contraindications, and weigh the benefits and risks of treatment. Participants will explore different formulations and regimens of MHT, learn how to address common myths and misinformation, and enhance their ability to use shared decision-making strategies when discussing MHT options with patients.

Speaker

At the conclusion of this session, participants will be able to: • Examine the latest medical treatments for endometriosis available today; • Contrast different medical management strategies for endometriosis, evaluating their benefits and limitations for various patient needs. This talk will explore current treatment guidelines and the full spectrum of medical management options available for endometriosis. The session will highlight when to initiate therapy and how to combine strategies effectively to optimize patient outcomes. Attendees will gain practical insights into evidence-based, multidisciplinary approaches to care.

Speaker

At the conclusion of this session, participants will be able to: • Recognize common early pregnancy complications, such as subchorionic hematoma, bleeding, and missed abortion; • Critique the effectiveness of management strategies for first trimester complications, including retained products of conception and miscarriage. This presentation will review a common finding in early pregnancy: subchorionic hemorrhages. We will learn about their diagnosis, clinical significance, management, and evaluate emerging evidence surrounding subchorionic hemorrhage in early pregnancy.

Speaker

Health Break

WHS Course Director

The Mary Cassaday Keynote Lecture. At the conclusion of this session, participants will be able to:• Discuss the reasons for and consequences of reproductive delay among women physicians, and specialty-specific differences;• Review barriers to adequate pregnancy accommodations and parental leave among physicians at all career stages, and discuss the importance of supporting physicians who are parents in the context of the health human resource crisis in Canada. Outline •Literature review on reproductive delay and adverse pregnancy outcomes among physicians overall and according to specialty, with a focus on the Ontario Dr. Mom cohort study. •Review what is known about adverse pregnancy outcomes among physicians overall and according to specialty. •Discuss barriers to and challenges of parenthood for physicians according to career stage and what we have learned from physicians through qualitative interviews. •Review Ontario data on work during pregnancy and parental leave among women physicians overall and according to specialty. •Discuss interventions that may support physicians who wish to be parents at any career stage, and the urgent need to change the current medical culture around family building. •Discuss parental leave policies and benefits in other industries that may be transferable to supporting physician parents.

Plenary Speaker

At the conclusion of this session, participants will be able to: • Explore medical treatments for overactive bladder to assess their effectiveness; • Assess the use of antimuscarinics and beta-3 agonists in treatment of overactive bladder.

Speaker

Health Break

At the conclusion of this session, participants will be able to: • Recognize the common causes of postmenopausal endometrial thickening and their clinical significance. • Apply a stepwise approach to the initial evaluation, including when and how to use transvaginal ultrasound and endometrial biopsy. • Determine appropriate thresholds for referral to gynecology and understand key management pathways. Clinical Context • Prevalence of incidental endometrial thickening in postmenopausal patients •Increasing use of imaging and incidental findings •Why this matters: balancing vigilance with avoidance of over-investigation Normal Postmenopausal Endometrium • Expected endometrial thickness in asymptomatic women •Hormonal changes and endometrial physiology post-menopause •TVUS appearance of normal endometrium Differential Diagnosis of Endometrial Thickening • Benign causes •Malignant or pre-malignant causes •Atrophic endometrium with technical over-measurement The Role of Symptoms • Key question: Is the patient symptomatic (bleeding) or asymptomatic? • Significance of postmenopausal bleeding •Implications for work-up and urgency Stepwise Diagnostic Approach • Initial workup •Thresholds Role of Transvaginal Ultrasound (TVUS) • How to interpret stripe measurements •When TVUS is reassuring •Limitations (e.g., poor visualization, interobserver variability) •Consideration of repeat imaging or saline infusion sonohysterography (SIS) When and How to Biopsy • Indications for endometrial sampling •Techniques: Pipelle, office biopsy, D&C •Contraindications and when to refer directly for hysteroscopy •When imaging or clinical picture supersedes stripe measurement

Speaker

At the conclusion of this session, participants will be able to: • Identify the underlying causes of acute and chronic vaginal discharge and recurrent yeast infections; • Propose evidence-based treatment plans for managing vaginal discharge to improve patient outcomes. This presentation will include a discussion on and management strategies for physiologic discharge, infectious discharge and chronic discharge.

Speaker

WHS Course Director